453 related articles for article (PubMed ID: 18719732)
41. Sterilization of Lucilia sericata (Diptera: Calliphoridae) Eggs for Maggot Debridement Therapy.
Bavani MM; Seyyedzadeh SJ; Radi E; Malekian A; Hoseinpour M; Gholizadeh S
J Med Entomol; 2022 May; 59(3):1076-1080. PubMed ID: 35187572
[TBL] [Abstract][Full Text] [Related]
42. Maggots do not survive in pyoderma gangrenosum.
Renner R; Treudler R; Simon JC
Dermatology; 2008; 217(3):241-3. PubMed ID: 18663307
[TBL] [Abstract][Full Text] [Related]
43. Acceleration of cutaneous wound healing by Lucilia sericata maggots in diabetic Wistar rats.
Borkataki S; Katoch R; Goswami P; Bhat A; Chakraborty D
Trop Biomed; 2021 Mar; 38(1):86-93. PubMed ID: 33797529
[TBL] [Abstract][Full Text] [Related]
44. Multiple actions of Lucilia sericata larvae in hard-to-heal wounds: larval secretions contain molecules that accelerate wound healing, reduce chronic inflammation and inhibit bacterial infection.
Cazander G; Pritchard DI; Nigam Y; Jung W; Nibbering PH
Bioessays; 2013 Dec; 35(12):1083-92. PubMed ID: 24123092
[TBL] [Abstract][Full Text] [Related]
45. The use of maggot debridement therapy in 41 equids.
Lepage OM; Doumbia A; Perron-Lepage MF; Gangl M
Equine Vet J Suppl; 2012 Dec; (43):120-5. PubMed ID: 23447891
[TBL] [Abstract][Full Text] [Related]
46. Do maggots have an influence on bacterial growth? A study on the susceptibility of strains of six different bacterial species to maggots of Lucilia sericata and their excretions/secretions.
Cazander G; van Veen KE; Bernards AT; Jukema GN
J Tissue Viability; 2009 Aug; 18(3):80-7. PubMed ID: 19362001
[TBL] [Abstract][Full Text] [Related]
47. Induction of antibacterial activity in larvae of the blowfly Lucilia sericata by an infected environment.
Kawabata T; Mitsui H; Yokota K; Ishino K; Oguma K; Sano S
Med Vet Entomol; 2010 Dec; 24(4):375-81. PubMed ID: 20946439
[TBL] [Abstract][Full Text] [Related]
48. Detection of anti-leishmanial effect of the Lucilia sericata larval secretions in vitro and in vivo on Leishmania tropica: first work.
Polat E; Cakan H; Aslan M; Sirekbasan S; Kutlubay Z; Ipek T; Ozbilgin A
Exp Parasitol; 2012 Oct; 132(2):129-34. PubMed ID: 22750454
[TBL] [Abstract][Full Text] [Related]
49. Maggot debridement therapy with Lucilia cuprina: a comparison with conventional debridement in diabetic foot ulcers.
Paul AG; Ahmad NW; Lee HL; Ariff AM; Saranum M; Naicker AS; Osman Z
Int Wound J; 2009 Feb; 6(1):39-46. PubMed ID: 19291114
[TBL] [Abstract][Full Text] [Related]
50. A human tissue-based assay identifies a novel carrion blowfly strain for maggot debridement therapy.
Yoshida T; Aonuma H; Otsuka S; Ichimura H; Saiki E; Hashimoto K; Ote M; Matsumoto S; Iwadate K; Miyawaki T; Kanuka H
Sci Rep; 2022 Jul; 12(1):12191. PubMed ID: 35842442
[TBL] [Abstract][Full Text] [Related]
51. Scanning electron microscopic evaluation of the successful sterilization of Lucilia cuprina (Wiedemann) utilized in maggot debridement therapy (mdt).
Yeong YS; Nazni WA; Santana RL; Mohd Noor I; Lee HL; Mohd Sofian A
Trop Biomed; 2011 Aug; 28(2):325-32. PubMed ID: 22041752
[TBL] [Abstract][Full Text] [Related]
52. Maggot excretion products from the blowfly Lucilia sericata contain contact phase/intrinsic pathway-like proteases with procoagulant functions.
Kahl M; Gökçen A; Fischer S; Bäumer M; Wiesner J; Lochnit G; Wygrecka M; Vilcinskas A; Preissner KT
Thromb Haemost; 2015 Aug; 114(2):277-88. PubMed ID: 25948398
[TBL] [Abstract][Full Text] [Related]
53. [Lucifensin, Chymotrypsin Proteins and Molecular Characterization of Lucilia sericata].
Erdoğan E; Karaca S
Mikrobiyol Bul; 2021 Jan; 55(1):81-90. PubMed ID: 33590983
[TBL] [Abstract][Full Text] [Related]
54. Biodebridement: a case report of maggot therapy for limb salvage after fourth-degree burns.
Namias N; Varela JE; Varas RP; Quintana O; Ward CG
J Burn Care Rehabil; 2000; 21(3):254-7. PubMed ID: 10850908
[TBL] [Abstract][Full Text] [Related]
55. Greenbottle (Lucilia sericata) larval secretions delivered from a prototype hydrogel wound dressing accelerate the closure of model wounds.
Smith AG; Powis RA; Pritchard DI; Britland ST
Biotechnol Prog; 2006; 22(6):1690-6. PubMed ID: 17137319
[TBL] [Abstract][Full Text] [Related]
56. An accidental but safe and effective use of Lucilia cuprina (Diptera: Calliphoridae) in maggot debridement therapy in Alexandria, Egypt.
Tantawi TI; Williams KA; Villet MH
J Med Entomol; 2010 May; 47(3):491-4. PubMed ID: 20496600
[TBL] [Abstract][Full Text] [Related]
57. [Comparative study of the efficacy of larva therapy for debridement and control of bacterial burden compared to surgical debridement and topical application of an antimicrobial].
Contreras-Ruiz J; Fuentes-Suárez A; Arroyo-Escalante S; Moncada-Barron D; Sosa-de-Martínez MC; Maravilla-Franco E; Domínguez-Cherit JG
Gac Med Mex; 2016 Oct; 152(Suppl 2):78-87. PubMed ID: 27792719
[TBL] [Abstract][Full Text] [Related]
58. Maggot therapy for venous stasis ulcers.
Sherman RA; Tran JM; Sullivan R
Arch Dermatol; 1996 Mar; 132(3):254-6. PubMed ID: 8607628
[No Abstract] [Full Text] [Related]
59. [Biosurgical débridement using Lucilia sericata-maggots - an update].
Nenoff P; Herrmann A; Gerlach C; Herrmann J; Simon JC
Wien Med Wochenschr; 2010 Dec; 160(21-22):578-85. PubMed ID: 20714816
[TBL] [Abstract][Full Text] [Related]
60. [Influence of maggot secretion on expression of bFGF and connective tissue growth factor in ulcer tissue of diabetes mellitus rat and antibacterium study].
Wang S; Lv D; Wang Y; Wang J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Apr; 22(4):472-5. PubMed ID: 18575452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
